Bahrain has granted emergency use authorisation to the COVID-19 vaccine developed by France’s Valneva (VLS.PA).
Valneva expects to deliver the first shipments of its VLA2001 vaccine to the kingdom at the end of March after it signed an advance purchase deal for one million doses in December last year.
